Key Protein That Keeps Metastatic Tumors in Latent and Asymptomatic Stage Identified

by Anjali Aryamvally on January 23, 2018 at 11:32 AM

The time needed for breast cancer metastases (secondary lesions caused by cells that have escaped from the original tumour) to develop varies between patients, and little is known about the mechanisms that govern latency. A study headed by Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light on the molecular basis underlying how the expression of certain genes facilitates the spread of metastatic lesions.

The team has studied the most common kind of breast tumour--estrogen-positive (ER +) and accounting for 80% of breast cancer tumour cases--that is characterised by a long period of latency with no symptoms. The study has been published in Nature Cell Biology.

Breast Cancer Screening using Mammogram

Breast cancer if detected early can be completely cured. Mammography is used to screen women for breast cancer.

‘Protein kinase MSK1 is a key regulator of dormant or latent metastases; breast cancers that do not express MSK1 are associated with a risk of earlier relapse, while those that express this molecule will form metastases later.’

Tweet it Now

MSK1, the protein that keeps tumour cells dormant

The team has identified the protein kinase MSK1 as a key regulator of dormant or latent metastases. Using clinical samples from patients, the scientists have confirmed that ER + breast cancer tumours that do not express MSK1 are associated with a risk of earlier relapse, while those that express this molecule will form metastases later.

Consumption of Red Meat Increases Breast Cancer Risk

Red meat consumption has long been suspected of contributing to cancer development. Find out how much red meat is too much.

"We are interested in understanding the mechanisms underlying metastasis and the time component of this process. Until now, little was known in preclinical models about the mechanisms that allow breast cancer cells to leave the latent state and even less is known in patients," explains Roger Gomis, head of the Growth Control and Cancer Metastasis Lab.

The researchers believe that in the future this discovery may benefit patients in two ways. Firstly, it will help to identify those with an imminent risk of relapse and to adjust the treatment for this prognosis. Secondly, attempts could be made to design a treatment to mimic the function of MSK1 kinase, with the aim to maintain metastatic lesions in a latent and asymptomatic state for as long as possible.

Source: Eurekalert

Font : A-A+

Inherited Breast Cancer Syndromes

Inherited breast cancers are caused due to mutations in genes that increase the risk of breast cancer in women.

<< Gold-nanoparticle-based Multifunctional Vehicle to Deliver G...

Marijuana Use Does Not Correlate With Lower Chances of Getti... >>

Breast Cancer Management: Advances

The crab that invades the breast is no more a fear factor with all the advancements that medical science and customized protocols can fight breast cancer. the recent developments in the management of breast cancer.